In this respect, preeclampsia, a disease model of systemic endothelial dysfunction, and some recent chemotherapy drugs that inhibit vascular endothelial growth factor (VEGF), share similar physiological mechanisms for the genesis of hypertension by inhibiting VEGF, reducing the production of NO and increasing systemic vascular resistance (SVR) [23]. This evidence concerns the gene VEGFA and preeclampsia.